For informational and research purposes only.
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Nutrition, performance and everyday health
A formula can increase perceived energy without improving the lifting outcome you care about. Read the evidence by product, endpoint and timescale.
Read articleTart-cherry trials distinguish less pain, faster strength recovery and lower inflammation. None automatically proves better long-term training adaptation.
Read articleA positive human trial adds promise, but starch type, diet, metabolic outcomes, and long-term weight control still need separate scrutiny.
Read articleVitamin C research depends on when supplementation starts and what it measures. Understand modest duration findings and the limits of treatment claims.
Read articleAshwagandha trials show some short-term symptom benefits, but a lower morning cortisol value does not prove a hormonal reset or long-term safety.
Read articleDirect caffeine comparisons now exist. Their small trials give different answers for cognitive tasks, rowing performance and subjective sleep.
Read articleOral glutathione can change measured body compartments in some trials. Explore what formulation studies show—and why clinical benefits need separate evidence.
Read articleD2 and D3 both raise vitamin D status, but not always equally. Understand fractional blood results, direct comparisons and the limits of clinical claims.
Read articleBacopa's studies distinguish delayed recall from immediate attention. Compare older positive trials with the 2025 trial's negative primary outcomes.
Read articleProtein is used during sleep, but bedtime studies do not all isolate timing. Compare overnight measurements, matched diets and longer training trials.
Read articleHMB studies ask different questions in bed rest, older age and resistance training. Here is what the human trials show about muscle and function.
Read articleSee why prebiotic-induced microbial changes and symptom relief can diverge, with human GOS, inulin and IBS trials and practical treatment questions.
Read article61–72 of 120 articles
